Fund Overview of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth
-
₹6,104.0 CrAUM
-
₹39.89NAV
-
1.05%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -7.56% | NA | 6.12% |
| 6 Months | -8.02% | NA | 12.92% |
| 1 Year | -0.03% | -0.03% | 6.04% |
| 2 Years | 25.13% | 11.86% | 24.93% |
| 3 Years | 106.33% | 27.31% | 25.71% |
| 5 Years | 127.19% | 17.84% | 19.91% |
| 7 Years | 292.55% | 21.57% | NA |
Asset Allocation
equities
97.98%debt instruments
0.03%other assets or cash equivalents
1.99%ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth is one Equity mutual fund offered by ICICI Prudential Mutual Fund. Launched on 13 Jul 2018, the fund aims Long term wealth creation. An equity Scheme that predominantly invests in pharma, healthcare, hospitals, diagnostics, wellness and allied companies. It manages assets worth ₹6,104.0 crore as on Thu Jul 31, 2025. The expense ratio stands at 1.05%. Fund Manager Manager Education Fund Manager Manager EducationAbout ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth
The portfolio allocation consists of 97.98% in equities, 0.03% in debt instruments, 1.99% in other assets or cash equivalents.Managed by Dharmesh Kakkad, it has delivered a return of -0.03% in the last year, a total return since inception of 19.68%.
Individuals frequently analyze the best sip to strengthen disciplined savings habits.
Key Metrics of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth
-
Standard Deviation15.52%
-
Sharpe Ratio1.32%
-
Alpha4.42%
-
Beta0.94%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -3.18% | -7.56% | -0.03% | 27.31% | 17.84% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -3.23% | -7.74% | -0.86% | 26.24% | 16.82% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -1.99% | -1.21% | 2.38% | 25.21% | 15.58% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -2.07% | -1.53% | 1.07% | 23.55% | 13.97% |
More funds from ICICI Prudential Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
|
₹6,104 | -3.23% | -7.74% | -8.41% | -0.86% | 26.24% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw
|
₹6,104 | -3.23% | -7.74% | -8.41% | -0.86% | 26.24% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw
|
₹6,104 | -3.18% | -7.56% | -8.02% | -0.03% | 27.31% |
|
ICICI Prudential Nifty Healthcare Etf - Growth
|
₹146 | -2.98% | -3.35% | -2.19% | 1.66% | 24.45% |
|
ICICI Prudential Nifty Pharma Index Fund - Growth
|
₹95 | -1.83% | -2.33% | -0.03% | 1.79% | 22.67% |
|
ICICI Prudential Nifty Pharma Index Fund Direct - Growth
|
₹95 | -1.78% | -2.18% | 0.28% | 2.42% | 23.44% |
|
ICICI Prudential Nifty Pharma Index Fund - Idcw
|
₹95 | -1.83% | -2.33% | -0.03% | 1.79% | 22.67% |
|
ICICI Prudential Nifty Pharma Index Fund Direct - Idcw
|
₹95 | -1.78% | -2.18% | 0.28% | 2.42% | 23.44% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹36.82 | 26.24% | 16.82% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹39.89 | 27.31% | 17.84% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹33.55 | 25.21% | 15.58% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹30.29 | 23.55% | 13.97% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹145.76 | 24.45% | - | - |
| ICICI Prudential Nifty Pharma Index Fund Direct - Growth |
₹95 | ₹17.20 | 23.44% | - | - |
| ICICI Prudential Nifty Pharma Index Fund - Growth |
₹95 | ₹16.85 | 22.67% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹14.62 | 24.62% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.83% | ₹828.54 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.05% | ₹777.92 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.88% | ₹764.80 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.88% | ₹764.80 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.21% | ₹762.45 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.20% | ₹745.57 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.58% | ₹721.19 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.69% | ₹713.48 Cr |
| Cipla Ltd | Healthcare | 9.40% | ₹639.45 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.81% | ₹634.02 Cr |
| Cipla Ltd | Healthcare | 9.43% | ₹627.97 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.42% | ₹606.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.42% | ₹606.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.10% | ₹566.95 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.50% | ₹547.49 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.50% | ₹547.49 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.75% | ₹544.91 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 8.85% | ₹540.22 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.64% | ₹519.83 Cr |
| Cipla Ltd | Healthcare | 8.00% | ₹516.67 Cr |
| Aurobindo Pharma Ltd | Healthcare | 8.25% | ₹513.73 Cr |
| Cipla Ltd | Healthcare | 7.90% | ₹509.92 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.82% | ₹505.14 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.13% | ₹496.29 Cr |
| Aurobindo Pharma Ltd | Healthcare | 7.62% | ₹490.41 Cr |
| Aurobindo Pharma Ltd | Healthcare | 7.62% | ₹490.41 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.27% | ₹483.96 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.48% | ₹482.98 Cr |
| Cipla Ltd | Healthcare | 7.54% | ₹460.34 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.10% | ₹458.33 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.52% | ₹443.63 Cr |
| Cipla Ltd | Healthcare | 6.92% | ₹430.94 Cr |
| Cipla Ltd | Healthcare | 6.61% | ₹425.53 Cr |
| Cipla Ltd | Healthcare | 6.61% | ₹425.53 Cr |
| Mankind Pharma Ltd. | Healthcare | 6.34% | ₹421.98 Cr |
| Biocon Ltd | Healthcare | 6.20% | ₹421.91 Cr |
| Mankind Pharma Ltd. | Healthcare | 6.44% | ₹415.63 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.22% | ₹414.30 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.95% | ₹404.34 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.04% | ₹390.15 Cr |
| Biocon Ltd | Healthcare | 5.85% | ₹389.71 Cr |
| Lupin Ltd | Healthcare | 5.78% | ₹373.31 Cr |
| Lupin Ltd | Healthcare | 5.70% | ₹368.47 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.71% | ₹348.35 Cr |
| Lupin Ltd | Healthcare | 5.40% | ₹347.47 Cr |
| Lupin Ltd | Healthcare | 5.40% | ₹347.47 Cr |
| Lupin Ltd | Healthcare | 5.43% | ₹338.23 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.19% | ₹335.21 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.04% | ₹325.27 Cr |
| Lupin Ltd | Healthcare | 4.80% | ₹319.57 Cr |
| Lupin Ltd | Healthcare | 5.11% | ₹312.02 Cr |
| Lupin Ltd | Healthcare | 3.99% | ₹271.04 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.91% | ₹260.34 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.98% | ₹256.14 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.98% | ₹256.14 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.05% | ₹252.35 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.70% | ₹251.39 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.78% | ₹244.06 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.88% | ₹236.58 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.66% | ₹236.40 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.47% | ₹235.88 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.83% | ₹234.03 Cr |
| Biocon Ltd | Healthcare | 3.64% | ₹222.32 Cr |
| Repo | Unspecified | 3.60% | ₹220.04 Cr |
| Syngene International Ltd | Healthcare | 3.16% | ₹215.17 Cr |
| Biocon Ltd | Healthcare | 3.28% | ₹211.36 Cr |
| Biocon Ltd | Healthcare | 3.28% | ₹211.36 Cr |
| Repo | Unspecified | 3.18% | ₹204.95 Cr |
| Repo | Unspecified | 3.18% | ₹204.95 Cr |
| Syngene International Ltd | Healthcare | 2.99% | ₹199.11 Cr |
| Gland Pharma Ltd | Healthcare | 3.20% | ₹195.59 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 3.01% | ₹194.11 Cr |
| Biocon Ltd | Healthcare | 3.11% | ₹193.70 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.90% | ₹193.01 Cr |
| Syngene International Ltd | Healthcare | 2.98% | ₹192.44 Cr |
| Syngene International Ltd | Healthcare | 2.97% | ₹191.65 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.77% | ₹188.49 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.80% | ₹186.43 Cr |
| Gland Pharma Ltd | Healthcare | 2.97% | ₹184.82 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.95% | ₹183.41 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.97% | ₹181.51 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.79% | ₹179.51 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.79% | ₹179.51 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.68% | ₹173.16 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.78% | ₹172.94 Cr |
| Medplus Health Services Ltd | Healthcare | 2.54% | ₹172.47 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.67% | ₹171.62 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.67% | ₹171.62 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.57% | ₹166.00 Cr |
| Repo | Unspecified | 2.48% | ₹164.84 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.49% | ₹161.04 Cr |
| Repo | Unspecified | 2.58% | ₹160.51 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.34% | ₹155.92 Cr |
| Syngene International Ltd | Healthcare | 2.50% | ₹152.34 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 2.28% | ₹151.53 Cr |
| Repo | Unspecified | 2.18% | ₹148.20 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 2.24% | ₹144.51 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 2.11% | ₹143.76 Cr |
| Repo | Unspecified | 2.23% | ₹143.75 Cr |
| Syngene International Ltd | Healthcare | 2.23% | ₹143.42 Cr |
| Syngene International Ltd | Healthcare | 2.23% | ₹143.42 Cr |
| Biocon Ltd | Healthcare | 2.20% | ₹142.14 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.07% | ₹140.91 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.15% | ₹139.02 Cr |
| Syngene International Ltd | Healthcare | 2.21% | ₹137.41 Cr |
| Repo | Unspecified | 2.09% | ₹134.90 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.08% | ₹134.20 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.08% | ₹134.20 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.03% | ₹130.62 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.03% | ₹130.62 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.94% | ₹125.00 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.91% | ₹123.26 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.91% | ₹123.26 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.89% | ₹122.13 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.77% | ₹120.43 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.85% | ₹119.41 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.79% | ₹119.29 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.75% | ₹118.84 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.75% | ₹118.70 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.77% | ₹117.79 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.77% | ₹113.91 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.77% | ₹113.91 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.81% | ₹112.88 Cr |
| Gland Pharma Ltd | Healthcare | 1.72% | ₹110.91 Cr |
| Gland Pharma Ltd | Healthcare | 1.72% | ₹110.91 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.71% | ₹110.63 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.71% | ₹110.62 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.60% | ₹108.88 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.63% | ₹108.44 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.62% | ₹108.19 Cr |
| Entero Healthcare Solutions Ltd. | Healthcare | 1.60% | ₹106.23 Cr |
| Gland Pharma Ltd | Healthcare | 1.59% | ₹106.16 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.70% | ₹106.15 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.63% | ₹105.31 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.72% | ₹105.07 Cr |
| Gland Pharma Ltd | Healthcare | 1.54% | ₹104.76 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.59% | ₹102.82 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.59% | ₹102.51 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.64% | ₹102.33 Cr |
| Gland Pharma Ltd | Healthcare | 1.57% | ₹101.16 Cr |
| Entero Healthcare Solutions Ltd. | Healthcare | 1.46% | ₹99.22 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.62% | ₹99.17 Cr |
| Gland Pharma Ltd | Healthcare | 1.53% | ₹99.00 Cr |
| Entero Healthcare Solutions Ltd. | Healthcare | 1.53% | ₹98.70 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.51% | ₹97.36 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.51% | ₹97.36 Cr |
| Medplus Health Services Ltd | Healthcare | 1.45% | ₹96.37 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.44% | ₹96.02 Cr |
| Pfizer Ltd | Healthcare | 1.46% | ₹94.27 Cr |
| Pfizer Ltd | Healthcare | 1.46% | ₹94.27 Cr |
| Pfizer Ltd | Healthcare | 1.54% | ₹94.00 Cr |
| Sagility India Ltd. | Industrials | 1.53% | ₹93.24 Cr |
| Pfizer Ltd | Healthcare | 1.34% | ₹91.34 Cr |
| Pfizer Ltd | Healthcare | 1.46% | ₹91.14 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.41% | ₹90.96 Cr |
| Pfizer Ltd | Healthcare | 1.40% | ₹90.26 Cr |
| Pfizer Ltd | Healthcare | 1.39% | ₹90.03 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.31% | ₹89.25 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.43% | ₹89.21 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.44% | ₹88.17 Cr |
| Medplus Health Services Ltd | Healthcare | 1.43% | ₹87.20 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.39% | ₹86.75 Cr |
| Medplus Health Services Ltd | Healthcare | 1.34% | ₹86.63 Cr |
| Medplus Health Services Ltd | Healthcare | 1.34% | ₹86.47 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.34% | ₹86.33 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.34% | ₹86.33 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.40% | ₹85.55 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.32% | ₹84.97 Cr |
| Windlas Biotech Ltd | Healthcare | 1.39% | ₹84.83 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.31% | ₹84.61 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.31% | ₹84.52 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.22% | ₹82.81 Cr |
| Pfizer Ltd | Healthcare | 1.24% | ₹82.59 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.21% | ₹82.29 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.23% | ₹82.07 Cr |
| Sagility India Ltd. | Industrials | 1.31% | ₹81.29 Cr |
| Windlas Biotech Ltd | Healthcare | 1.26% | ₹81.09 Cr |
| Windlas Biotech Ltd | Healthcare | 1.26% | ₹81.09 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.19% | ₹80.94 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.32% | ₹80.84 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.32% | ₹80.79 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.29% | ₹80.13 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.31% | ₹79.91 Cr |
| Fine Organic Industries Ltd | Materials | 1.31% | ₹79.67 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹79.45 Cr |
| Medplus Health Services Ltd | Healthcare | 1.23% | ₹79.11 Cr |
| Medplus Health Services Ltd | Healthcare | 1.23% | ₹79.11 Cr |
| Hikal Ltd | Healthcare | 1.15% | ₹78.46 Cr |
| Aarti Drugs Ltd | Healthcare | 1.28% | ₹78.18 Cr |
| Windlas Biotech Ltd | Healthcare | 1.25% | ₹77.69 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.16% | ₹77.24 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.19% | ₹77.10 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.15% | ₹76.37 Cr |
| Hikal Ltd | Healthcare | 1.15% | ₹76.28 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹75.61 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹75.61 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹75.29 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.17% | ₹75.12 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.17% | ₹75.12 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 1.23% | ₹74.82 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.16% | ₹74.75 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.16% | ₹74.75 Cr |
| Aarti Drugs Ltd | Healthcare | 1.19% | ₹73.99 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.19% | ₹73.97 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.09% | ₹73.82 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.14% | ₹73.73 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.14% | ₹73.63 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.14% | ₹73.63 Cr |
| Aarti Drugs Ltd | Healthcare | 1.14% | ₹73.09 Cr |
| Aarti Drugs Ltd | Healthcare | 1.14% | ₹73.09 Cr |
| Hikal Ltd | Healthcare | 1.13% | ₹72.95 Cr |
| Windlas Biotech Ltd | Healthcare | 1.09% | ₹72.81 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.12% | ₹72.58 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.17% | ₹72.54 Cr |
| Fine Organic Industries Ltd | Materials | 1.09% | ₹72.31 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.11% | ₹71.64 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.11% | ₹71.64 Cr |
| Medplus Health Services Ltd | Healthcare | 1.14% | ₹70.98 Cr |
| Aarti Drugs Ltd | Healthcare | 1.10% | ₹70.88 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.16% | ₹70.77 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.14% | ₹70.69 Cr |
| Fine Organic Industries Ltd | Materials | 1.09% | ₹70.14 Cr |
| Aarti Drugs Ltd | Healthcare | 1.04% | ₹69.51 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.06% | ₹68.58 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.10% | ₹68.39 Cr |
| Windlas Biotech Ltd | Healthcare | 1.06% | ₹68.19 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.06% | ₹67.97 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.06% | ₹67.97 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.09% | ₹67.88 Cr |
| Fine Organic Industries Ltd | Materials | 1.08% | ₹67.35 Cr |
| Windlas Biotech Ltd | Healthcare | 1.04% | ₹67.21 Cr |
| Aarti Drugs Ltd | Healthcare | 0.98% | ₹66.95 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.03% | ₹66.81 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.97% | ₹65.97 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.02% | ₹65.78 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.07% | ₹65.18 Cr |
| Windlas Biotech Ltd | Healthcare | 0.95% | ₹64.75 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.04% | ₹63.43 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.95% | ₹63.08 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.96% | ₹61.86 Cr |
| Aarti Drugs Ltd | Healthcare | 0.96% | ₹61.75 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.88% | ₹59.94 Cr |
| Hikal Ltd | Healthcare | 0.92% | ₹59.12 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.91% | ₹58.78 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.91% | ₹58.78 Cr |
| Advanced Enzyme Technologies Ltd | Materials | 0.95% | ₹58.10 Cr |
| Fdc Ltd | Healthcare | 0.94% | ₹57.41 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.92% | ₹57.05 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.85% | ₹56.71 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.85% | ₹56.62 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.86% | ₹55.62 Cr |
| Fdc Ltd | Healthcare | 0.86% | ₹55.17 Cr |
| Fdc Ltd | Healthcare | 0.86% | ₹55.17 Cr |
| Hikal Ltd | Healthcare | 0.84% | ₹54.22 Cr |
| Hikal Ltd | Healthcare | 0.84% | ₹54.22 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.84% | ₹54.17 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.83% | ₹53.90 Cr |
| Fdc Ltd | Healthcare | 0.85% | ₹52.97 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.82% | ₹52.79 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.82% | ₹52.69 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.82% | ₹52.57 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.82% | ₹52.57 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.84% | ₹52.28 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.85% | ₹51.87 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.76% | ₹51.57 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.79% | ₹51.17 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.79% | ₹51.17 Cr |
| Fdc Ltd | Healthcare | 0.78% | ₹50.67 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.83% | ₹50.54 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.78% | ₹50.51 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.78% | ₹50.51 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.76% | ₹50.50 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.80% | ₹50.10 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.80% | ₹49.88 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.75% | ₹49.83 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.77% | ₹49.68 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.77% | ₹49.65 Cr |
| Fdc Ltd | Healthcare | 0.77% | ₹49.63 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.77% | ₹49.42 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.77% | ₹49.42 Cr |
| Rubicon Research Ltd. | 0.74% | ₹49.38 Cr | |
| Rubicon Research Ltd. | 0.76% | ₹49.13 Cr | |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.71% | ₹48.39 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.77% | ₹47.78 Cr |
| Rubicon Research Ltd. | 0.73% | ₹47.33 Cr | |
| Procter & Gamble Health Ltd | Healthcare | 0.75% | ₹45.99 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.71% | ₹45.84 Cr |
| Fdc Ltd | Healthcare | 0.68% | ₹45.24 Cr |
| Rubicon Research Ltd. | 0.69% | ₹44.61 Cr | |
| Rubicon Research Ltd. | 0.69% | ₹44.61 Cr | |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.72% | ₹44.15 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.71% | ₹44.10 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.68% | ₹44.07 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.68% | ₹44.07 Cr |
| Fdc Ltd | Healthcare | 0.63% | ₹42.72 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.63% | ₹42.52 Cr |
| Sagility India Ltd. | Industrials | 0.66% | ₹42.22 Cr |
| Sagility India Ltd. | Industrials | 0.66% | ₹42.22 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.63% | ₹41.73 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.63% | ₹40.90 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.67% | ₹40.87 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.63% | ₹40.76 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.63% | ₹40.50 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.63% | ₹40.50 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.62% | ₹40.29 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.61% | ₹38.29 Cr |
| Nephrocare Health Services Ltd. | 0.48% | ₹32.65 Cr | |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.45% | ₹30.67 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.46% | ₹30.43 Cr |
| Nephrocare Health Services Ltd. | 0.44% | ₹29.02 Cr | |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.44% | ₹28.68 Cr |
| Hikal Ltd | Healthcare | 0.44% | ₹27.60 Cr |
| Nephrocare Health Services Ltd. | 0.39% | ₹25.47 Cr | |
| Net Current Assets | Unspecified | 0.37% | ₹22.68 Cr |
| Rubicon Research Ltd. | 0.26% | ₹17.72 Cr | |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 0.24% | ₹15.05 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.13% | ₹8.90 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.13% | ₹8.68 Cr |
| Cash Margin | Unspecified | 0.14% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Advanced Enzyme Technologies Ltd | Materials | 0.07% | ₹4.47 Cr |
| 91 Dtb (09-apr-2026) | Financial | 0.03% | ₹1.99 Cr |
| 91 Dtb (09-apr-2026) | Financial | 0.03% | ₹1.98 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.01% | ₹0.62 Cr |
| Cash Margin | Unspecified | 0.01% | ₹0.41 Cr |
| Cash Margin | Unspecified | 0.01% | ₹0.41 Cr |
| Net Payables | Unspecified | -0.06% | ₹-3.87 Cr |
| Net Payables | Unspecified | -0.09% | ₹-5.90 Cr |
| Net Payables | Unspecified | -0.11% | ₹-7.32 Cr |
| Net Payables | Unspecified | -0.19% | ₹-13.21 Cr |
| Net Payables | Unspecified | -0.26% | ₹-16.22 Cr |
| Net Payables | Unspecified | -0.41% | ₹-26.44 Cr |
| Net Payables | Unspecified | -0.41% | ₹-26.44 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹39.89 | 27.31% | 17.84% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹36.82 | 26.24% | 16.82% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹33.55 | 25.21% | 15.58% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹30.29 | 23.55% | 13.97% | - |
Frequently Asked Questions
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth
What is the current AUM of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth?
As of Thu Jul 31, 2025, ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth manages assets worth ₹6,104.0 crore
What is the long-term performance of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth?
- 3 Years CAGR: 27.31%
- 5 Years CAGR: 17.84%
- Since Inception: 19.68%
What is the portfolio composition of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth?
Equity: 97.98%, Debt: 0.03%, Others: 1.99%.
Who manages ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth?
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth is managed by Dharmesh Kakkad from ICICI Prudential Mutual Fund.
What is the market-cap allocation of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth?
Large Cap: 33.76%, Mid Cap: 29.95%, Small Cap: 36.29%.
Which are the top companies ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth has invested in?
- Sun Pharmaceutical Industries Ltd – 12.83% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.05% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.88% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.88% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.21% of the fund's portfolio
Which are the major sectors ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth focuses on?
- Healthcare – 740.54% of the fund's portfolio
- Unspecified – 21.16% of the fund's portfolio
- Industrials – 17.17% of the fund's portfolio
- Materials – 10.27% of the fund's portfolio
- Financial – 5.67% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





